@RedMedEd

Redefining Medical Education

 Malvern, PA
education.redmeded.com
Joined December 2013
  • Tweets2.4K
  • Following325
  • Followers283
777Media
Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer? This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
A doctor in a white coat with a stethoscope around her neck is sitting at a wooden table. She is writing notes in a notebook, with an open laptop beside her.

ALT A doctor in a white coat with a stethoscope around her neck is sitting at a wooden table. She is writing notes in a notebook, with an open laptop beside her.

1
1
1
305
Replying to @HadidiSamer
Strange to have approval before publication. Hope we will have a publication ASAP.
1
4
9
1,779
Free @RedMedEd CE opportunity! How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer? Learn from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care.
1
2
1
321
How can clinicians integrate ctDNA, ICIs, and ADCs into the management of muscle-invasive bladder cancer? Continuing education from experts @ERPlimackMD @siadaneshmand and Colleen H. Tetzlaff, MHS, PA-C on emerging biomarkers, personalized treatment strategies, and the importance of a multidisciplinary approach to MIBC care. @RedMedEd
A medical professional in a white coat and teal scrubs is seated while writing in a notebook. She is holding a tablet in her other hand and wearing glasses. A stethoscope and a blood pressure cuff are placed on the table in front of her. Her expression appears focused and engaged.

ALT A medical professional in a white coat and teal scrubs is seated while writing in a notebook. She is holding a tablet in her other hand and wearing glasses. A stethoscope and a blood pressure cuff are placed on the table in front of her. Her expression appears focused and engaged.

1
2
3
654
⚠️ CDC estimates that nearly 500,000 American suffer from Alpha-gal syndrome, with emerging evidence suggesting that number is potentially in the millions. “We intend to bring the same urgency, innovation, and scientific rigor to Alpha-gal syndrome that we are to Lyme disease.” —@SecKennedy
138
271
32
1,173
123,562
Replying to @VincentRK
This is what happens with the work all the folks here have done
2
15
1
48
17,950
Think you’re up to date on the AEs associated with bladder cancer immunotherapy? Find out in this game-based CME activity developed for APPs, nurses, and other HCPs who treat bladder cancer. @RedMedEd
1
1
241
31% of patients needed to travel by air to be diagnosed with amyloid. ⁦@SLentzsch⁩ sharing key lessons for all doctors to have their clinical hats on to avoid missing this diagnosis ! #mmsm
3
12
53
3,101
Did you know that immune checkpoint inhibitors have become a key option for muscle-invasive bladder cancer and locally advanced/metastatic bladder cancer? This @RedMedEd CME activity covers emerging immunotherapies (and how to use them) and other important advances in BC management.
A doctor in a white coat with a stethoscope around her neck is sitting at a wooden table. She is writing notes in a notebook, with an open laptop beside her.

ALT A doctor in a white coat with a stethoscope around her neck is sitting at a wooden table. She is writing notes in a notebook, with an open laptop beside her.

1
1
2
316
Replying to @BladderCancerUS @RedMedEd
Find out more: bit.pulse.ly/i8wqhbsnvs
Alt text: Image with a purple background displaying steps leading to a peak. The text "Managing Immunotherapy-Related Toxicities in Bladder Cancer" appears at the top. Overlaid are bold words "SCALE BAIL or FAIL." A hand holds a smartphone showing a quiz question. BCAN and PA logos are present at the bottom.

ALT Alt text: Image with a purple background displaying steps leading to a peak. The text "Managing Immunotherapy-Related Toxicities in Bladder Cancer" appears at the top. Overlaid are bold words "SCALE BAIL or FAIL." A hand holds a smartphone showing a quiz question. BCAN and PA logos are present at the bottom.

1
122
From new immunotherapies to AE management, this game-based CME activity from tests your bladder cancer care acumen while presenting essential information to help keep your practice current and your patients thriving. @RedMedEd
1
1
1
166
Med oncs, urologists, APPs, onc nurses: if you see bladder cancer (BC) patients, don’t miss this CME Clinical Callout activity with @RedMedEd
Smiling female doctor with stethoscope reading medical documents.

ALT Smiling female doctor with stethoscope reading medical documents.

1
1
1
202
Wow!!! #ASH2025
1
8
45
3,020
Ready, set… hunt! 👀 Join the first-ever #ASHScavengerHunt at #ASH25! Explore, snap, and share your experience at the 2025 ASH Annual Meeting and Exposition. Register now: bit.ly/3K7pgo3
1
13
5
24
8,156
Good news for myeloma patients #mmsm gsk.com/en-gb/media/press-re…

Blenrep approved by US FDA for use in treatment of relapsed/refractory multiple myeloma | GSK

Blenrep is the only anti-BCMA accessible in the community setting where 70% of patients receive care.

gsk.com
1
3
9
832
From No Hope to a Potential Cure for a Deadly Blood Cancer @ginakolata #mmsm #ciltacel nytimes.com/2025/06/03/healt…

From No Hope to a Potential Cure for a Deadly Blood Cancer (Published 2025)

Multiple myeloma is considered incurable, but a third of patients in a Johnson & Johnson clinical trial have lived without detectable cancer for years after facing certain death.

nytimes.com
1
5
2
17
2,858
The @US_FDA ODAC recommends approval of daratumumab (Darzalex) for high-risk smoldering myeloma. The MMRF supports access to safe and effective treatments for all patients and research to better define this population. #MultipleMyeloma #theMMRF
5
16
1,897
An @US_FDA ODAC will be held May 20th to discuss the potential approval for Dara in smoldering myeloma #mmsm Very good points made in the discussion 👇 ➡️ fda.gov/media/186527/downloa… Few important observations summarised here🧵
2
9
3
33
9,454
Link to study in @BloodJournal : ashpublications.org/blood/ar…

Sustained bone marrow and imaging MRD negativity for 3 years drives discontinuation of maintenance...

Key PointsThe TFS rate at 36 months after lenalidomide maintenance discontinuation was 75.8% (95% confidence interval, 64-90).Of the 12 patients who revers

ashpublications.org
1
337
1/3🧵 🔥Hot off the press. ⭐️My co-authors & I are excited to share this just published paper @ASCO #ASCO25 #ASCOEdBook on a topic that is near & dear to my heart: ✅“The ART of #Oncology #Education & #Knowledge Sharing. It is All About the “#How” 👇🏻 ascopubs.org/doi/10.1200/EDB…
4
46
4
139
27,170
Load more